Summary
- Current Price
- As of today, AVLN price is $26.40, up +2.64% on
- Current Price All-Time High
- AVLN price is currently -18.09% below its historical high of $32.23 set on
- Market Cap
- AVLN current market cap is $1B, with unknown 1-year change
- PE Ratio
- AVLN PE ratio is unknown
- Revenue
- AVLN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for AVLN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Avalyn Pharma Inc. |
| Ticker | NASDAQ: AVLN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | avalynpharma.com |
| Employees | 50 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $26.40 | |
| Price, 1D Change | +2.64% | |
| $1B | ||
| - | ||
| - | ||
| 0.00 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| - | ||
| EPS, 1Y Change | - |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| - | ||
| EPS Estimate | N/A | -$1.94 |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $26.40 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.94 | N/A | - | |
| -$1.90 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $26.40 | |
| $28.25 | ||
| $28.25 | ||
| - | ||
| - | ||
| - | ||
| 0.00 | ||
| $2.38 | ||
| 41.76 | ||
| 68.25% | ||
| 71.70% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| - | ||
| - | ||
| - | ||
| -$91.29M | ||
| - | ||
| -$85.20M | ||
| - | ||
| -$91.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.01 | ||
| 10.19 | ||
| - | ||
| - | ||
| N/A | - | |
| -1.66 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$238.66M | ||
| $52.32M | ||
| $148.88M | ||
| $143.56M | ||
| $387.54M | ||
| $14.09M | ||
| $1.67M | ||
| - | ||
| $3.76M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $91.29M | ||
| $91.29M | ||
| - | ||
| $14.68M | ||
| $42.00K | ||
| - | ||
| - |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$81.48M | ||
| $10.06M | ||
| $99.79M | ||
| $344.00K | ||
| -$81.83M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Morgan Stanley | ||
| Guggenheim | ||
| Evercore ISI Group |
Analyst sentiment
Institutional ownership
Screeners with AVLN
FAQ
What is the ticker symbol for Avalyn Pharma Inc.?
The ticker symbol for Avalyn Pharma Inc. is NASDAQ:AVLN
Does Avalyn Pharma Inc. pay dividends?
No, Avalyn Pharma Inc. does not pay dividends
What sector is Avalyn Pharma Inc. in?
Avalyn Pharma Inc. is in the Healthcare sector
What industry is Avalyn Pharma Inc. in?
Avalyn Pharma Inc. is in the Biotechnology industry
What country is Avalyn Pharma Inc. based in?
Avalyn Pharma Inc. is headquartered in United States
When did Avalyn Pharma Inc. go public?
Avalyn Pharma Inc. initial public offering (IPO) was on April 30, 2026
Is Avalyn Pharma Inc. in the S&P 500?
No, Avalyn Pharma Inc. is not included in the S&P 500 index
Is Avalyn Pharma Inc. in the NASDAQ 100?
No, Avalyn Pharma Inc. is not included in the NASDAQ 100 index
Is Avalyn Pharma Inc. in the Dow Jones?
No, Avalyn Pharma Inc. is not included in the Dow Jones index
When does Avalyn Pharma Inc. report earnings?
The next expected earnings date for Avalyn Pharma Inc. is June 3, 2026
Data Sources & References
- AVLN Official Website www.avalynpharma.com
- AVLN Profile on Yahoo Finance finance.yahoo.com/quote/AVLN
- AVLN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avln